Monday, August 30, 2010

Cordial invitation from the Indian Association of Community Ophthalmology

Leprosy Mailing List – August 29th, 2010

Ref.: Cordial invitation from the Indian Association of Community Ophthalmology (see attachments)
From: Swapan K Samanta, West Bengal, India

Dear Dr. Noto,
I shall be highly obliged if you are kind enough to circulate the following invitation.
Swapan K Samanta
Hon. Secretary, Indian Association of Leprologists.
Hon. Secretary, Indian Association of Community Ophthalmology





Respected Sir/Madam,

Here is a cordial INVITATION from Indian Association of Community Ophthalmology to all our collegue engaged / interested in Community Ophthalmology (DOCTORS OF ANY DISCIPLINE, OPTOMETRISTS, OPHTHALMIC ASSISTANTS, MANAGERIAL AUTHORITY OF GOVT/ NGO / EYE HOSPITAL /PROJECTS & RESEARCH WORKERS IN THE FIELD OF OPHTHALMIC EPIDEMIOLOGY, GENETICS, IMMUNOLOGY AND STATISTICS AND MEDICAL STUDENTS WITH POSTER PRESENTATION). On the occasion of OCULAR LEPROSY SESSION at the International Symposium on Community Ophthalmology to be held in Kolkata, West Bengal, India on 30th. & 31st. October, 2010 .

Ocular Leprosy:
Convenor: Dr. Swapan K. Samanta
Chairpersons :
Dr. Shyamla Anand (Kothara)
Prof. Atul Shah(Mumbai)
Moderator: Dr. M A Rajan( Kumbakonam , TN )
Rapporteur: Dr. Helen Roberts (Kolkata)
Key Note : Dr. Felix Brandt ( Germany )
Key Note. : Mrs. Neela Shah (Mumbai)
Key Note : Padmashree Prof. Sai Baba Gour ( Hyderabad )

His Excellency The Honourable Governor of the State of West Bengal is expected to inaugurate the Session along with the kind presence of the Honourable Union Minister of Health & Family Welfare & State Cabinet Minister of Health & Family Welfare namely Mr. Dinesh Trivedi & Dr. Surya Kanta Mishra respectively. , Dr. V M Katoch, Past President, Indian Association of Leprologists (Secretary, Dept. of Health Research, Ministry of Health & Family Welfare, Govt of India & Director General, Indian Council for Medical Research) will give away the Theme Address & Dr. G N Rao (Chairman, L V Prasad Eye Hospital, Hyderabad & Past President, IAPB) will deliver the Concluding Remarks.

An expected number of one thousand delegates from five continents of the world will participate in these two days vibrating sessions to interact with the major issues of Community Ophthalmology at this crucial midpoint of the launch of VISION 2020, the Global Initiative for Prevention of Blindness , The Right to Sight.

Looking forward for your kind participation.

Please be kind enough to circulate the News of this International Symposium through your official WEBSITE of your organization.



Simultaneous Four Session in Four halls

Hall A : Theme Session (Community Ophthalmology)

Hall B : Update Session ( Advancement in the field of major Eye Diseases)

(Keeping pace with the theme of the Symposium)

Hall C : Free Paper Session ( Presentation of performance at your set up )

Hall D: Video Presentation (Presentation of performance on Individual/ Group/ Institution basis)

POSTER : (Presentation of performance on Individual/ Group/ Institution basis)

Local Contact Persons

1. Dr.P L Saha"Dr. Pannalal Saha" ,
2. Dr.Debashish Bhattacharya, ,
3. Dr. Debdas Mukhrajee (Chairman, Reception Committee) : ,bkgddmei1,
4. Dr. Ratish Pal, ,
5. Dr. J Bhunia (Jt. Organising Secretary): bhunialine11bhunialine(at)
6. Dr. Subhankar Home, ,
7. Dr. Debashish Das, ,
8. Dr. Amitabha Roy Chowdhury (Chairman, Scientific Committee) : amitabharc,
9. Dr. Sudipta Dey (Treasurer) ,
10. Dr. K Fariduddin (Jt. Treasurer) "k_fariduddin" ,

National Co ordinators :
1. Eastern India : Dr. B N R Subudhi, "b.n.r subudhi" , "nageswar subudhi" ,
2. Western India : Col. Dr. Madan Deshpande VSM,"desaieyehospital" , "desaieyehospital" ,

3. Northern India : Dr. Raghab Ram Sukul, "rrshukul" ,

4. Southern India : Dr. B Motilal, "Joint Director NPCB" ,

5. Central India : Dr.Sudhir Mahashabde "sudhir.mahashabde",

Urgent reply please,
Swapan K Samanta

Enclosure :

1. Brochure
2. List of faculties
3. Scientific Programme at a glance

(The Travel Point
One Stop Travel Shoppe
206 Manglam A
24 Hemant Basu Sarani, Near Great Eastern Hotel
Kolkata -700001, India, PH : +91 33 22488851 , 3020 7969 , 2213 8617, 94330 24636
e.mail : travelpoint(at)
skype : lionraj)
6. Official Co ordinator for Sponsor Programme
Zenith Enterprise
C/O Mrs. Smita Chatterjee
Zenith Enterprise
5 Purbachal School Road ,Kolkata - 700078.
0983645742, 033 64514377,
Email: Zenith Enterprise

Can drug used in leprosy (Clofazimine, Dapsone, Rifampicin and Prednisolone) cause hyponatraemia?

Leprosy Mailing List – August 29th, 2010

Ref.: Can drug used in leprosy (Clofazimine, Dapsone, Rifampicin and Prednisolone) cause hyponatraemia?

From: Ben Naafs, Munnekeburen, The Netherlands

Dear dr Idi,

It may be that I missed it. But I have never seen it. I also did a small internet search. I think that the internist has to look for another cause.

With kind regards.

Ben Naafs

Can drug used in leprosy (Clofazimine, Dapsone, Rifampicin and Prednisolone) cause hyponatraemia?

Leprosy Mailing List – August 29th, 2010

Ref.: Can drug used in leprosy (Clofazimine, Dapsone, Rifampicin and Prednisolone) cause hyponatraemia?

From: Lysbeth Duncan, Peebles , Scotland , UK

Dear Dr. Noto,

I refer to Mr
Adamou Idi’s message dated LML Aug. 23rd, 2010. Having used the four drugs listed without seeing any evidence of hyponatraemia, personally I am not aware of this being a problem.

I do know that Rifampicin reduces the efficacy of prednisolone by 50%, as can oral contraceptives. I shall forward this letter to a colleague who is a leprologist and Microbiologist in case he can help further.

Best regards,

Lysbeth Duncan


Rifampicin reduces effectiveness and bioavailability of prednisolone

w a c mcallister, p j thompson, s m al-habet, h j rogers

british medical journal volume 286 19 march 1983

Clofazimine in ENL reaction

Leprosy Mailing List – August 29th, 2010

Ref.: Clofazimine in ENL reaction

From: Ailton Santos Romero, Caruaru, Pernambuco , Brazil

Dear Dr. Noto

Drugs currently used in the treatment of reactions in leprosy are: non-steroidal anti-inflammatory drugs (NSAIDs), corticosteroids, and thalidomide. Thalidomide is the treatment of choice in erythema nodosum leprosum (ENL) or type 2 reaction, except for women of child bearing age.

In our centre, prednisolone and thalidomide, in men only, are the drugs of choice in ENL. In the past in patients with relapsing and chronic ENL reaction we have also used a regimen containing clofazimine. We found it useful in cases of steroid dependent ENL. The doses of clofazimine that we used were:

300mg, the first month
200mg the second month
100mg in the third month
50mg in treatment continued until remission of the clinical picture.

Unfortunately loose clofazimine is currently not available in our country.

I would like asking the experience of colleagues about the use of such a regimen, particularly about the time of regression of the reaction using clofazimine. We had excellent results with clofazimine, do others confirm this?

Thank you very much in advance for your collaboration.

My sincere compliments,

Dr. Ailton Santos Romero

Reference Regional Medical Center
Leprosy and AIDS -
Health Department City of Caruaru
Pernambuco State



Health Center , Amelia Bridges
Avenida Guararapes, S / N - Centre
City of Caruaru CEP 55000-000
Pernambuco State


Digital photos needed of people who are reading

Leprosy Mailing List – August 27th, 2010

Ref.: Digital photos needed of people who are reading

From: Jiske Erlings, Amsterdam, The Netherlands

Greetings from Infolep,

As you might or might not know Infolep is currently working on a new website. It should be ready later this year.

For the design of the website I would like to use photos of people from around the world using information resources (reading a book, sitting in a library, using a computer or using a mobile device or e-reader).

I would be very grateful if you could help me with this. You could send me existing photo's or make some new ones.

Many thanks in advance.

With kind regards,

Jiske Erlings

INFOLEP Leprosy Information Services

P.O. Box 95005

Tel.: + 31 20 5950530

Fax: + 31 20 6680823

Email: infolep(at)


Infolep catalogue:

BIKASH Nepal , training announcement 2011

Leprosy Mailing List – August 24th, 2010

Ref.: BIKASH Nepal , training announcement 2011 (see attachment)
From: G. Gurung, Pokhara , Nepal

Dear Dr. Salvatore,

Welcome back and greetings from Nepal !

Kindly, arrange to publish our training announcement 2011 (below) through the Leprosy Mailing List. We thank you very much for your invaluable support.

With our best wishes !

Gopal Gurung

International training announcement 2011:

Please find attached the course announcement for the following international courses.

Course title
Training and Communication Skills (TCS):
17-28 January 2011
Rehabilitation and Prevention of Disability (RPOD):
07-18 March 2011
Community Based Rehabilitation (CBR):
21 March- 01 April 2011

For further information, please contact:

Gopal Gurung
Program Manager
PO Box: 28

Phone: 00977 61 430562
Fax: 00977 61 430940
E-mail: ggurung(at)

Leprosy-related courses being held at ALERT in the coming months

Leprosy Mailing List – August 24th, 2010

Ref.: Leprosy-related courses being held at ALERT in the coming months (see attachments)
From: E. Kebede, Addis Ababa , Ethiopia

Dear Dr Noto,

Thank you for announcing (LML 22 08 2010) to LML members the upcoming CBR course at ALERT, which will be organized in collaboration with Enablement, from November 15-26th, 2010.

May we take the opportunity to remind LML members of four other leprosy-related courses being held at ALERT in the coming months:

Clinical leprosy and tropical dermatology for Physicians: September 13-17th (1 week); €565.

Clinical leprosy and management of combined leprosy, TB & HIV/AIDS control programmes for senior field staff: October 18 – November 5th (3 weeks); €1700.

Rehabilitation and Prevention of Disabilities: October 25 – November 12th (3 weeks); €1700.

Operational research methods in epidemiology: December 6-10th (1 week); €565.

The attached 2010 training calendar contains further details, and the application form can be completed and returned to ALERT for any of these courses.

Thank you,

Dr Eshetu Kebede
Training Director
ALERT centre
Tel. +251 11 321 13 41/51
Fax: +251 11 321 13 51
E-mail: leprosytb(at)
Addis Ababa , Ethiopia

Can drug used in leprosy (Clofazimine, Dapsone, Rifampicin and Prednisolone) cause hyponatraemia?

Leprosy Mailing List – August 23rd, 2010

Ref.: Can drug used in leprosy (Clofazimine, Dapsone, Rifampicin and Prednisolone) cause hyponatraemia?

From: Adamou Idi , Niger

Dear Dr Salvatore

I greet you in the name of our Almighty God. Sir, let me to introduce myself to you, my name is Adamou Idi and I have been involved in the Leprosy Control Programme since 1993, I have been trained by many visitors like Dr Francoise Luthi.

We have a multibacillary leprosy patient on treatment, he is on at his fifth blister package, and is in severe leprosy reaction type 2 (ENL). He has been suffering with fever for more than 3 weeks, he has lost weight. The doctor that we are working with asked some questions about the sides effects of leprosy drugs like Clofazimine, Dapsone, Rifampicin and Prednisolone. Can they cause hyponotraemia? The patient has very low blood sodium.

We would greatly appreciate any advice.

With kinds regards,

Thank you

Adamou Idi

Community Based Rehabilitation course, Addis Ababa , Ethiopia , 15 – 26November 2010

Leprosy Mailing List – August 22nd, 2010

Ref.: Community Based Rehabilitation course, Addis Ababa , Ethiopia , 15 – 26November 2010

From: H Cornielje, Alphen aan den Rijn, The Netherlands

Dear Salvatore,

I would be very pleased if you could send the following text to the members of the list.

With warm regards.


ALERT in Ethiopia in collaboration with ENABLEMENT in The Netherlands will organize from the 15th to the 26th of November, 2010, for the 3rd consecutive year, a highly successful 2-week training in Community Based Rehabilitation

Target group: Health and social workers (including physiotherapists, occupational therapists and project managers) as well as disability activists involved in or new to management of CBR programmes.

Objective of the course is that participants will have a working knowledge of all the important aspects related to CBR. Beside theoretical sessions there will be a variety of practical (skill) sessions and a field trip. Topics covered include disability in Africa , CBR, project management cycle, community participation, disability rights, violence towards children with disabilities, DPOs, socio-economic rehabilitation, micro-credit, measuring quality of life, advocacy and networking.

Course facilitator: Mr Huib Cornielje and Marieke Boersma

Training site: Training Division of ALERT, ADDIS ABABA , ETHIOPIA

Tuition fee Euro 550/course/person

Living/accommodation fee: Euro 40/day/person

There are still a few places available.

For more information: contact the Training Division of ALERT at

and you can request an application form.

or visit ALERT website:


Huib Cornielje


A van Leeuwenhoekweg 38 unit A16
Lions Gate
2408 AN Alphen aan den Rijn

The Netherlands

tel: 0031-172-499940

Tel: 0031-172-436953 (private)

Mobile : 0031-6-28485083

Fax: 0031-172-244976

E-mail: h.cornielje(at)

Internet: and

Skype: enablement

Monday, August 16, 2010

Diagnosis of leprosy

Some time ago Dr Noto and Dr Schreuder had prepared some learning materials on diagnosis of leprosy that was presented through different messages on Leprosy Mailing List.

This is to inform that now all the different files of these materials related to diagnosis of leprosy - introduction to leprosy, cardinal signs of leprosy and clinical spectrum of leprosy are now available all together from Leprosy Mailing List archives in both PDF as well as the original file formats (word document and powerpoint slides) at the following link: